40540 Federal Register / Vol. 87, No. 129 / Thursday, July 7, 2022 / Notices 

U.S.C. 545, was for conduct relating to 

the importation into the United States of 

any drug or controlled substance 

because she illegally imported 

unapproved new drugs containing 

botulinum toxin to use in treatments she 

conducted on individuals for money. In 

proposing a debarment period, FDA 

weighed the considerations set forth in 

section 306(c)(3) of the FD&C Act that 

it considered applicable to Ms. 

Novikov’s offense and concluded that 

the offense warranted the imposition of 

a 5-year period of debarment. 

The proposal informed Ms. Novikov 

of the proposed debarment, offered her 

an opportunity to request a hearing, 

providing her 30 days from the date of 

receipt of the letter in which to file the 

request, and advised her that failure to 

request a hearing constituted a waiver of 

the opportunity for a hearing and of any 

contentions concerning this action. Ms. 

Novikov received the proposal and 

notice of opportunity for a hearing at 

her residence on March 9, 2022. Ms. 

Novikov failed to request a hearing 

within the timeframe prescribed by 

regulation and has, therefore, waived 

her opportunity for a hearing and 

waived any contentions concerning her 

debarment (21 CFR part 12). 

II. Findings and Order 

Therefore, the Assistant 

Commissioner, Office of Human and 

Animal Food Operations, under section 

306(b)(3)(C) of the FD&C Act, under 

authority delegated to the Assistant 

Commissioner, finds that Ms. Jhanna 

Novikov has been convicted of a felony 

under Federal law for conduct relating 

to the importation into the United States 

of any drug or controlled substance. 

FDA finds that the offense should be 

accorded a debarment period of 5 years 

as provided by section 306(c)(2)(A)(iii) 

of the FD&C Act. 

As a result of the foregoing finding, 

Ms. Novikov is debarred for a period of 

5 years from importing or offering for 

import any drug into the United States, 

effective (see DATES). Pursuant to section 

301(cc) of the FD&C Act (21 U.S.C. 

331(cc)), the importing or offering for 

import into the United States of any 

drug or controlled substance by, with 

the assistance of, or at the direction of 

Ms. Novikov is a prohibited act. 

Any application by Ms. Novikov for 

termination of debarment under section 

306(d)(1) of the FD&C Act should be 

identified with Docket No. FDA–2021– 

N–1358 and sent to the Dockets 

Management Staff (see ADDRESSES). The 

public availability of information in 

these submissions is governed by 21 

CFR 10.20(j). 

Publicly available submissions will be 

placed in the docket and will be 

viewable at https://www.regulations.gov 

or at the Dockets Management Staff (see 

ADDRESSES) between 9 a.m. and 4 p.m., 

Monday through Friday, 240–402–7500. 

Dated: June 30, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–14433 Filed 7–6–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Lists of Designated Primary Medical 

Care, Mental Health, and Dental Health 

Professional Shortage Areas 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice informs the public 

of the availability of the complete lists 

of all geographic areas, population 

groups, and facilities designated as 

primary medical care, dental health, and 

mental health professional shortage 

areas (HPSAs) in a designated status as 

of April 29, 2022. The lists are available 

on the shortage area topic page on 

HRSA’s data.hrsa.gov website. Given 

the COVID–19 pandemic’s impact on 

the health workforce and health care 

service delivery, HRSA is providing a 

longer transition time for jurisdictions 

and facilities to prepare for potential 

change of HPSA designations. HPSA 

designations that are currently proposed 

for withdrawal will remain in this status 

until they are re-evaluated in 

preparation for the publication of the 

2023 HPSA Federal Register Notice. If 

these HPSAs do not meet the 

requirements for designation at the time 

of the publication of the July 2023 

HPSA Federal Register Notice next 

year, they will be withdrawn. This 

additional time will allow jurisdictions 

to re-evaluate their HPSAs against the 

designation criteria, and plan for 

potential changes in staffing. 

ADDRESSES: Complete lists of HPSAs 

designated as of April 29, 2022, and 

updated information on HPSAs are 

available on the website at https://

data.hrsa.gov/topics/health-workforce/ 

shortage-areas. Information on shortage 

designations is available at https://

bhw.hrsa.gov/workforce-shortage-areas/ 

shortage-designation. 

FOR FURTHER INFORMATION CONTACT: For 

further information on the HPSA 

designations listed on the website or to 

request additional designation, 

withdrawal, or reapplication for 

designation, please contact Janelle D. 

McCutchen, DHEd, MPH, CHES, Chief, 

Shortage Designation Branch, Division 

of Policy and Shortage Designation, 

Bureau of Health Workforce (BHW), 

HRSA, 5600 Fishers Lane, Room 

11W14, Rockville, Maryland 20857, 

sdb@hrsa.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

Section 332 of the Public Health 

Service (PHS) Act, 42 U.S.C. 254e, 

provides that the Secretary shall 

designate HPSAs based on criteria 

established by regulation. HPSAs are 

defined in section 332 to include (1) 

urban and rural geographic areas with 

shortages of health professionals, (2) 

population groups with such shortages, 

and (3) facilities with such shortages. 

Section 332 further requires that the 

Secretary annually publish lists of the 

designated geographic areas, population 

groups, and facilities. The lists of 

HPSAs are to be reviewed at least 

annually and revised as necessary. 

Final regulations (42 CFR part 5) were 

published in 1980 that include the 

criteria for designating HPSAs. Criteria 

were defined for seven health 

professional types: primary medical 

care, dental, psychiatric, vision care, 

podiatric, pharmacy, and veterinary 

care. The criteria for correctional facility 

HPSAs were revised and published on 

March 2, 1989 (54 FR 8735). The criteria 

for psychiatric HPSAs were expanded to 

mental health HPSAs on January 22, 

1992 (57 FR 2473). Currently funded 

PHS Act programs use only the primary 

medical care, mental health, or dental 

HPSA designations. 

HPSA designation offers access to 

potential federal assistance. Public or 

private nonprofit entities are eligible to 

apply for assignment of National Health 

Service Corps personnel to provide 

primary medical care, mental health, or 

dental health services in or to these 

HPSAs. National Health Service Corps 

health professionals enter into service 

agreements to serve in federally 

designated HPSAs. Entities with clinical 

training sites located in HPSAs are 

eligible to receive priority for certain 

residency training program grants 

administered by HRSA’s Bureau of 

Health Workforce (BHW). Other federal 

programs also utilize HPSA 

designations. For example, under 

authorities administered by the Centers 

for Medicare and Medicaid Services, 

certain qualified providers in 

geographic area HPSAs are eligible for 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 129 / Thursday, July 7, 2022 / Notices 40541 

increased levels of Medicare 

reimbursement. 

Content and Format of Lists 

The three lists of designated HPSAs 

are available on the HRSA Data 

Warehouse shortage area topic web page 

and include a snapshot of all geographic 

areas, population groups, and facilities 

that were designated HPSAs as of April 

29, 2022. This notice incorporates the 

most recent annual reviews of 

designated HPSAs and supersedes the 

HPSA lists published in the Federal 

Register on July 7, 2021 (Federal 

Register/Vol. 86, No. 127/Wednesday, 

July 7, 2021/Notices 35808). Note that 

HPSA designations that are currently 

proposed for withdrawal will remain in 

this status until they are re-evaluated in 

preparation for the publication of the 

2023 HPSA Federal Register Notice. 

In addition, all Indian Tribes that 

meet the definition of such Tribes in the 

Indian Health Care Improvement Act of 

1976, 25 U.S.C. 1603, are automatically 

designated as population groups with 

primary medical care and dental health 

professional shortages. Further, the 

Health Care Safety Net Amendments of 

2002 provides eligibility for automatic 

facility HPSA designations for all 

federally qualified health centers 

(FQHCs) and rural health clinics that 

offer services regardless of ability to 

pay. Specifically, these entities include 

FQHCs funded under section 330 of the 

PHS Act, FQHC Look-Alikes, and Tribal 

and urban Indian clinics operating 

under the Indian Self-Determination 

and Education Act of 1975 (25 U.S.C. 

450) or the Indian Health Care 

Improvement Act. Many, but not all, of 

these entities are included on this 

listing. Absence from this list does not 

exclude them from HPSA designation; 

facilities eligible for automatic 

designation are included in the database 

when they are identified. 

Each list of designated HPSAs is 

arranged by state. Within each state, the 

list is presented by county. If only a 

portion (or portions) of a county is (are) 

designated, a county is part of a larger 

designated service area, or a population 

group residing in a county or a facility 

located in the county has been 

designated, the name of the service area, 

population group, or facility involved is 

listed under the county name. A county 

that has a whole county geographic or 

population group HPSA is indicated by 

the phrase ‘‘County’’ following the 

county name. 

Development of the Designation and 

Withdrawal Lists 

Requests for designation or 

withdrawal of a particular geographic 

area, population group, or facility as a 

HPSA are received continuously by 

BHW. Under a Cooperative Agreement 

between HRSA and the 54 state and 

territorial Primary Care Offices (PCOs), 

PCOs conduct needs assessments and 

submit applications to HRSA to 

designate areas as HPSAs. BHW refers 

requests that come from other sources to 

PCOs for review. In addition, interested 

parties, including Governors, State 

Primary Care Associations, and state 

professional associations, are notified of 

requests so that they may submit their 

comments and recommendations. 

BHW reviews each recommendation 

for possible addition, continuation, 

revision, or withdrawal. Following 

review, BHW notifies the appropriate 

agency, individuals, and interested 

organizations of each designation of a 

HPSA, rejection of recommendation for 

HPSA designation, revision of a HPSA 

designation, and/or advance notice of 

pending withdrawals from the HPSA 

list via the Shortage Designation 

Management System. Designations (or 

revisions of designations) are effective 

as of the date on the notification from 

BHW and are updated daily on the 

HRSA Data Warehouse website. While 

this list is a snapshot of HPSAs at a 

point in time, HPSA designations are 

regularly being updated so the best 

source of current designation status is 

the HRSA Data Warehouse website at 

(https://data.hrsa.gov/tools/shortagearea). 

Designations proposed for withdrawal 

will remain in that status and not be 

withdrawn unless they do not meet the 

HPSA designation criteria at the time 

the Fiscal Year 2023 HPSA Federal 

Register Notice is developed and 

published. 

Carole Johnson, 

Administrator. 

[FR Doc. 2022–14501 Filed 7–6–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Proposed 

Reorganization 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development (NICHD) will host 

a meeting to enable public discussion of 

the Institute’s proposal to reorganize its 

Division of Extramural Research. 

DATES: This virtual public meeting will 

take place on August 8 from 10:00– 

11:00 a.m. ET. Members of the public 

are welcome to attend and do not need 

to RSVP. 

ADDRESSES: The meeting will take place 

at via webinar at https://

nih.zoomgov.com/j/1606532813. 

American Sign Language interpreting 

services are available upon request. 

Individuals who need interpreting 

services and/or other reasonable 

accommodations to participate in this 

event, should contact Elizabeth 

Cushman at Elizabeth.cushman@

nih.gov. Requests should be made at 

least five business days in advance in 

order to ensure interpreter availability. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Jessica Wu, Chief of the Management 

Analysis and Workforce Branch, Eunice 

Kennedy Shriver National Institute of 

Child Health and Human Development, 

31 Center Drive, Bethesda, MD 20892, 

telephone: 301–443–3219, email: wuj5@

mail.nih.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with the NIH Reform Act of 

2006 (42 U.S.C. Sec.281 (d)(4)), NICHD 

will have a public meeting to discuss 

the proposed reorganization plans. 

NICHD proposal would simplify the 

organizational structure of the NICHD, 

create new organizational components 

to reduce ‘siloing’, increase 

administrative efficiencies, facilitate 

transdisciplinary research and idea 

exchange, and benefit the institute’s 

internal and external communities. The 

proposal seeks to capitalize on emerging 

scientific opportunities, while reducing 

barriers to scientific and 

interdisciplinary collaboration. 

Dated: July 1, 2022. 

Alison N. Cernich, 

Deputy Director, Eunice Kennedy Shriver 

National Institute of Child Health and Human 

Development, National Institutes of Health. 

[FR Doc. 2022–14432 Filed 7–6–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Regents of the 

National Library of Medicine. 


khammond on DSKJM1Z7X2PROD with NOTICES